Endocrinology conferences

The conference examines diabetes from molecular causes to new treatments. Researchers connect genetics and pathobiology with therapeutic strategies and associated metabolic, cardiovascular and renal conditions, seeking explanations for unmet needs and opportunities to alter disease progression.

The conference studies cardiovascular and metabolic disease through communication among organs. Researchers examine interactions involving cardiac, renal, muscle, hepatic, immune and nervous systems, connecting mechanistic discoveries with emerging approaches to therapy.

This meeting examines adipose tissue as a regulator of metabolism, thermogenesis, immunity and endocrine communication. Researchers connect cellular mechanisms with systemic physiology and disease, including interactions with incretin biology and translational approaches to adipose dysfunction.

The conference connects basic and clinical research on incretin hormones with pharmaceutical development. Researchers examine mechanisms underlying metabolic treatments and emerging applications, discussing what remains unknown about GLP-1, GIP and approaches to obesity and associated diseases.

The 61st Annual Meeting of the Scandinavian Society for the Study of Diabetes (SSSD) takes place in Reykjavík on 27 and 28 May 2027. The international meeting brings together researchers, clinicians and professionals from across diabetology to share new science, exchange perspectives, foster collaborations and explore ideas for the future of diabetes research and care, over two days of keynote lectures, scientific sessions and discussion. Abstract submission opened on 15 September 2026; the abstract deadline is 1 March 2027 and the early-bird registration deadline is 15 March 2027.

The International Symposium on Chromaffin Cell Biology is a biennial meeting on adrenal chromaffin cells and their wider relevance to cellular and neurobiological function, held since 1982. The 23rd edition, organised at the University of Innsbruck, links the field's strengths in secretion biology and excitation–secretion coupling with developmental biology, neuroendocrine disease and new technologies. It treats the chromaffin cell both as a classical model of regulated secretion and as a model for neuroendocrine development, stress adaptation and disease. Preliminary themes are excitation–secretion coupling; vesicle biology and regulated secretion; chromogranins and secretory cargo; development, plasticity and regeneration; stress physiology and disease, including pheochromocytoma, paraganglioma and neuroblastoma; and emerging technologies such as single-cell omics, lineage tracing, advanced imaging, electrophysiology and organoids. Studies of related neuroendocrine and secretory systems, from neurons to endocrine and immune cells, are welcome. The programme will include plenary and invited lectures, abstract-selected talks, poster sessions, workshops and early-career opportunities. Typical attendance is 120–180 participants.

Researchers discuss how cells and tissues adapt to changing nutrient conditions. The conference emphasizes insulin-responsive metabolic tissues and integrated physiology, connecting shared sensing mechanisms with obesity, diabetes and other consequences of disrupted metabolic regulation.